HCM
HURA

Hodges Capital Management’s TuHURA Biosciences HURA Stock Holding History

Hodges Capital Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.9K Hold
10,000
– – ﹤0.01% 199
2025
Q4 		$7.57K Buy
+10,000
New +$19.1K ﹤0.01% 196

Other funds holding HURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return

Hodges Capital Management's HURA Position: Q1 2026 in Review

Hodges Capital Management held its TuHURA Biosciences (HURA) position steady in Q1 2026 at 10,000 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #199.

Hodges Capital Management first reported a position in HURA in Q4 2025 and has held it in 2 quarters since. 89 funds tracked by Wall St. Rank hold HURA as of Q1 2026.

  • Hodges Capital Management held 10,000 shares of TuHURA Biosciences worth $17.9K as of Q1 2026.
  • Hodges Capital Management left its TuHURA Biosciences share count unchanged in Q1 2026.
  • TuHURA Biosciences made up ﹤0.01% of Hodges Capital Management's portfolio in Q1 2026, its #199 holding.
  • Hodges Capital Management first reported a position in TuHURA Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q1 2026.

Based on Hodges Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.